Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to provide continuing access to BMN 044 treatment for subjects
previously treated with BMN 044. The information gained from this study is expected to
further characterize the efficacy and safety of BMN 044 over a longer treatment period.